OR

Browse By

Define the mode of action for Cdc7 inhibition in TP53 wild type and mutant Acute Myeloid Leukemia (AML) (2023–2025)

Grant type:
Schrodinger Inc.
Researchers:

  • Dr Mathew Jones

    Senior Lecturer
    School of Chemistry and Molecular Biosciences
    Faculty of Science
    Senior Research Fellow
    Frazer Institute
    Faculty of Medicine
    Senior Research Fellow
    Frazer Institute
    Faculty of Medicine
Funded by:
Schrodinger Inc.